Mucin anchoring of SARS-CoV-2 neutralizing nanobinders increases intranasal antiviral efficacy
Joelton Rocha Gomes, Juliette Jacquelin, Amélie Donchet, Nathalie Lejal, Quentin Nevers, Bernard Klonjkowski, Sophie Le Poder, Bernard Delmas, Nicolas Meunier
This study shows that anchoring a SARS-CoV-2 neutralizing nanobinder to mucin increases its residence time in the nasal cavity, enhancing antiviral efficacy in hamsters.
bioRxiv · Apr 10, 2025 · PreprintMicrobiology